196 phd-rehabilitation-engineering-computer-science Postdoctoral research jobs at University of Oxford in Uk
-
induced by radiotherapy. You will employ a broad range of experimental approaches, including cell line engineering, transcriptional reporter assays, flow cytometry, qRT-PCR, ELISA, and CRISPR-based genetic
-
until 30 March 2026, and may be extended subject to the availability and renewal of external funding. With a background in materials science, materials processing or related engineering or physical
-
and leading a programme of numerical simulations relating to all aspects of our research on P-MoPAs; using particle-in-cell computer codes hosted on local and national high-performance computing
-
to 2-3 lectures or tutorial per year. About you You will hold a PhD/Dphil (or near to completion) in field relating to cancer biology, immunology or cell biology. You will possess exceptional
-
an available option. Applicants with a range of academic subject backgrounds are welcomed, including natural sciences, epidemiology, engineering, statistics and applied mathematics with experience and
-
radiation technology. Prior experience on spin-resolved ARPES or previous experience in setting up and maintain the operation of ARPES spectrometers will be an advantage. Candidates are expected
-
choice theory, or computational modelling. This post is based at the Department of Computer Science and on-site working is required. Remote and part-time working is possible in agreement with Professor
-
Williams research and group here About you Applicants must hold a PhD in Polymerization catalysis (or be close to completion) prior to taking up the appointment. The research requires experience in carbon
-
use computational approaches to mine natural biodiversity in gene sequences to identify engineering targets to increase lipid content and enhance the water use efficiency. The project will make use
-
at the Oxford Eye Hospital. Over the past decade, Dr Kapetanovic has been at the forefront of basic science and translational medical research into novel clinical treatments for incurable retinal diseases